Retargeting of adenoviral vectors to neurons using the Hc fragment of tetanus toxin

被引:20
作者
Schneider, H
Groves, M
Mühle, C
Reynolds, PN
Knight, A
Themis, M
Carvajal, J
Scaravilli, F
Curiel, DT
Fairweather, NF
Coutelle, C [1 ]
机构
[1] Imperial Coll Sch Med, Div Biomed Sci, Mol Genet Sect, London SW7 2AZ, England
[2] UCL, Neurol Inst, Dept Neuropathol, London, England
[3] Univ Alabama Birmingham, Gene Therapy Program, Birmingham, AL USA
[4] Univ London Imperial Coll Sci Technol & Med, Dept Biochem, London, England
关键词
tetanus toxin; adenovirus; retargeting; nervous system; gene transfer;
D O I
10.1038/sj.gt.3301270
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The H-C fragment of tetanus toxin (H-C) retains the specific nerve cell binding and transport properties of the holotoxin, but lacks any toxicity. We are investigating the potential for utilising its neurotropism for targeted gene delivery to the central nervous system. Previously we reported the use of H-C-polylysine conjugates for selective gene transfer into neuronal cells in vitro. However, as attempts to apply these constructs in vivo were not successful, we have extended these studies to modification of the tropism of adenoviral vectors. Either H-C-polylysine conjugates or the Fab fragment of a neutralising anti-knob antibody covalently bound to H-C were attached to the virus. Infection of neuronal and nonneuronal cell lines with retargeted virus showed highly increased neuronal cell selectivity, but no significant enhancement of gene delivery into these cells. High concentrations of free H-C blocked the infectivity of the retargeted vector efficiently. Intramuscular injection of retargeted virus into mouse tongues resulted in selective gene transfer to the neurons of the hypoglossal nucleus, where no pathological changes were observed As differentiated neurons do not undergo cell division, appropriate vectors carrying a thymidine kinase gene, which allows selective elimination of dividing cells, may be exploitable for the treatment of tumours of the central nervous system. The demonstrated suitability of the H-C fragment of tetanus toxin as targeting moiety for viral vectors also indicates a potential for gene therapy of inherited neurodegenerative diseases such as spinal muscular atrophy.
引用
收藏
页码:1584 / 1592
页数:9
相关论文
共 37 条
[1]   Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli [J].
Chartier, C ;
Degryse, E ;
Gantzer, M ;
Dieterle, A ;
Pavirani, A ;
Mehtali, M .
JOURNAL OF VIROLOGY, 1996, 70 (07) :4805-4810
[2]   Construction of hybrid proteins that migrate retrogradely and transsynaptically into the central nervous system [J].
Coen, L ;
Osta, R ;
Maury, M ;
Brulet, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (17) :9400-9405
[3]   THE CHALLENGE OF FETAL GENE-THERAPY [J].
COUTELLE, C ;
DOUAR, AM ;
COLLEDGE, WH ;
FROSTER, U .
NATURE MEDICINE, 1995, 1 (09) :864-866
[4]   NEURONAL LYSOSOMAL-ENZYME REPLACEMENT USING FRAGMENT-C OF TETANUS TOXIN [J].
DOBRENIS, K ;
JOSEPH, A ;
RATTAZZI, MC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (06) :2297-2301
[5]   Targeted gene delivery by tropism-modified adenoviral vectors [J].
Douglas, JT ;
Rogers, BE ;
Rosenfeld, ME ;
Michael, SI ;
Feng, MZ ;
Curiel, DT .
NATURE BIOTECHNOLOGY, 1996, 14 (11) :1574-1578
[6]   TRANSSYNAPTIC RETROGRADE TRANSPORT OF FRAGMENT-C OF TETANUS TOXIN DEMONSTRATED BY IMMUNOHISTOCHEMICAL LOCALIZATION [J].
EVINGER, C ;
ERICHSEN, JT .
BRAIN RESEARCH, 1986, 380 (02) :383-388
[7]   CHARACTERIZATION OF RECOMBINANT TETANUS TOXIN DERIVATIVES SUITABLE FOR VACCINE DEVELOPMENT [J].
FIGUEIREDO, D ;
TURCOTTE, C ;
FRANKEL, G ;
LI, Y ;
DOLLY, O ;
WILKIN, G ;
MARRIOTT, D ;
FAIRWEATHER, N ;
DOUGAN, G .
INFECTION AND IMMUNITY, 1995, 63 (08) :3218-3221
[8]   Delivery of recombinant tetanus-superoxide dismutase proteins to central nervous system neurons by retrograde axonal transport [J].
Figueiredo, DM ;
Hallewell, RA ;
Chen, LL ;
Fairweather, NF ;
Dougan, G ;
Savitt, JM ;
Parks, DA ;
Fishman, PS .
EXPERIMENTAL NEUROLOGY, 1997, 145 (02) :546-554
[9]  
Fink DJ, 1996, ANNU REV NEUROSCI, V19, P265
[10]   Development of an HSV-based vector for the treatment of Parkinson's disease [J].
Fink, DJ ;
Poliani, PL ;
Oligino, T ;
Krisky, DM ;
Goins, WF ;
Glorioso, JC .
EXPERIMENTAL NEUROLOGY, 1997, 144 (01) :103-112